-+ 0.00%
-+ 0.00%
-+ 0.00%

Immunovant CEO Eric Venker disposes of common shares worth $2.93 million

PUBT·10/05/2026 23:43:09
Listen to the news
Immunovant CEO Eric Venker disposes of common shares worth $2.93 million
  • Immunovant CEO and director Eric Venker increased his direct stake to 257,075 shares following CVAR settlement.
  • 92,187 shares were acquired on Oct. 1, 2026 at $14.46 per share via an exercise transaction.
  • 85,886 shares were disposed of on Oct. 1, 2026 at $33.65 per share.
  • Another 3,506 shares were sold on Oct. 2, 2026 at $34.11 per share to cover tax withholding.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunovant Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001764013-26-000110), on October 05, 2026, and is solely responsible for the information contained therein.